REBISCAN

Pharmaceutical & medical device company payment data from CMS Open Payments.

Total Payments
$97,650
Doctors Paid
21
Transactions
84
2023 Total
$30,827

Payment Breakdown by Category

Consulting$90,000 (92.2%)
Royalty/License$7,264 (7.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $90,000 3 92.2%
Royalty or License $7,264 3 7.4%
Gift $385.31 3 0.4%
Unspecified $0 75 0.0%

Payments by Type

General
$97,650
9 transactions
Ownership
$0
75 transactions

Payments by Medical Specialty

Specialty Total Paid Doctors Avg/Doctor
Psychiatry $90,000 1 $90,000
Pediatric Ophthalmology and Strabismus Specialist $250.00 3 $83.33
Ophthalmology $135.31 7 $19.33
Dentist $0 1 $0
Emergency Medicine $0 1 $0
Family Medicine $0 2 $0
Foot & Ankle Surgery $0 1 $0
Internal Medicine $0 2 $0
Orthopaedic Surgery $0 2 $0
Vascular & Interventional Radiology $0 1 $0

Top Paid Doctors

Doctor Specialty Location Total 2023
Dr. Lee Goldstein, M.d., Ph.d, M.D., PH.D Psychiatry Boston, MA $90,000 $0
Dr. Irene Tung, M.d, M.D Ophthalmology The Woodlands, TX $135.31 $0
Christie Morse, Md, MD Pediatric Ophthalmology and Strabismus Specialist Concord, NH $135.00 $0
Dorothy Moore, M.d, M.D Pediatric Ophthalmology and Strabismus Specialist Wilmington, DE $115.00 $0

About REBISCAN

REBISCAN has made $97,650 in payments to 21 healthcare providers, recorded across 84 transactions in the CMS Open Payments database. In 2023, the company paid $30,827. The top product by payment volume is Blinq ($97,650).

Payments were distributed across 10 medical specialties. The top specialty by payment amount is Psychiatry ($90,000 to 1 doctors).

Payment categories include: Consulting ($90,000), Royalties ($7,264).

REBISCAN is associated with 1 products in the CMS Open Payments database.